Skip to main content
NIH funding notice RFA-AI-13-024

Pharmacological Approaches to Evaluating Drug Regimens to Address Antimicrobial Resistance (R01)

Closed on July 30, 2013.

Posted
April 18, 2013
Close date
July 30, 2013
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,152,782 in first-year total cost, median $825,019.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 FDS-M (J2)]6
  2. ZAI1-FDS-M(J2)3

Most frequent institutions

  1. UNIVERSITY OF FLORIDA2
  2. GEORGETOWN UNIVERSITY1
  3. JOHNS HOPKINS UNIVERSITY1
  4. MONASH UNIVERSITY1
  5. RBHS-NEW JERSEY MEDICAL SCHOOL1
Competing awards under RFA-AI-13-024 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models1R01AI111970-01BROWN, ASHLEYDRUSANO, GEORGE LOUISUNIVERSITY OF FLORIDA, FL$1,147,252ZAI1
2014Combination Therapy Modeling for M tuberculosis Resistance Suppression and Kill1R56AI111974-01DRUSANO, GEORGE LOUISLOUIE, ARNOLDUNIVERSITY OF FLORIDA, FL$1,075,032ZAI1
2014Optimized Combination Antimalarial Drug Therapy1R01AI111962-01ROEPE, PAUL D.SULLIVAN, DAVID JOSEPHGEORGETOWN UNIVERSITY, DC$1,055,093ZAI1
2014New Tricks for 'Old' Drugs: PK/PD of Polymyxin Nonantibiotic Combinations1R01AI111965-01LI, JIANMONASH UNIVERSITY$905,775ZAI1
2014Novel PK/PD Strategies for Polymyxin Combinations against Gram-negative Superbugs1R01AI111990-01LI, JIANTSUJI, BRIANSTATE UNIVERSITY OF NEW YORK AT BUFFALO, NY$825,019ZAI1
2014De facto monotherapy during multidrug TB treatment and emergence of resistance1R01AI111967-01ALLAND, DAVIDDARTOIS, VERONIQUERBHS-NEW JERSEY MEDICAL SCHOOL, NJ$802,715ZAI1
2014Integrative Pharmacology Approach to Understand Mechanisms of TB Drug Resistance1R01AI111992-01DOOLEY, KELLY E.NUERMBERGER, ERIC LJOHNS HOPKINS UNIVERSITY, MD$659,598ZAI1
2014Optimized Antimicrobial Combinations to Suppress Resistance1R56AI111793-01NIKOLAOU, MICHAELTAM, VINCENT HUNIVERSITY OF HOUSTON, TX$518,760ZAI1
2014Short course therapy for MDR-TB based on PK/PD answers for biological variability1R56AI111985-01GUMBO, TAWANDAUT SOUTHWESTERN MEDICAL CENTER, TX$163,538ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-13-024: Pharmacological Approaches to Evaluating Drug Regimens to Address Antimicrobial Resistance (R01) | ScienceDex | ConductScience